What happens after the fermenter

The vessel is an excellent object for a photograph. Stainless steel catches the light; pipes suggest controlled complexity; the familiar cow or egg is conspicuously absent. It looks like a decisive change in how food is made. What it cannot show is whether the substance emerging from the process is affordable, consistent and useful in the food someone wants to sell.

Precision fermentation uses microorganisms to make a chosen substance, such as a particular protein. EFSA’s explanation of the technology distinguishes that process from growing animal cells. It also points to established uses in medicines and food enzymes. The newer commercial challenge is not simply demonstrating that microbes can make useful molecules; it is extending that capability to ingredients and markets with their own requirements.

A protein for a dessert, for example, has to do a job in a mixture. It arrives with a specification, joins other ingredients, passes through a customer’s equipment and encounters storage and distribution. A production process succeeds commercially when it can repeat that journey, not merely when a sample is recovered from a promising experiment.

Follow that route outward and several questions replace the image of the tank: what feeds the organism, what comes out alongside the desired substance, how the ingredient is recovered, and what the buyer actually needs it to do. The answers connect biotechnology to ordinary food manufacturing.

At the inlet: the inputs still come from somewhere

An organism needs resources. A fermentation process therefore has a supply chain even when it replaces an animal-derived ingredient. Feedstocks, water, utilities and process materials have to be obtained, with the consistency required by the production system. Removing one familiar farm animal from the photograph does not remove every relationship with agriculture or energy.

The appropriate comparison depends on the production route. A process using an agricultural sugar and one using another carbon source should not borrow each other’s environmental account. Nor can a plan to use a future input be treated as evidence that the current factory already runs on it. The distinction is important when an industry discusses both today’s ingredients and a much wider future set of possibilities.

It also matters for resilience. A business can change the source of a food protein and remain exposed to the price or availability of another input. The risk has moved rather than necessarily disappeared. A buyer deciding whether the ingredient improves supply security needs information about the new dependencies as well as the one being reduced.

For the producer, resource use belongs beside output. A fermentation result expressed only as concentration in a vessel may be useful to a scientist but incomplete for someone buying the final powder. The commercial account needs to reach the quantity of usable ingredient leaving the process, and the resources spent getting it there.

At the outlet: making a protein and recovering it are different jobs

The recovered ingredient has to be separated from a production mixture and brought to its required specification. That downstream work is easy to compress into a single arrow in a presentation. It deserves more space in the business story.

A 2026 review by J. K. Keppler and R. M. Boom examines this problem for food proteins. Methods suited to highly purified, high-value products can be expensive for bulk foods. The authors discuss approaches centered on useful food functionality, including foaming, emulsification and gel formation, rather than pursuing purity as an isolated objective. They also note that many proposed alternatives still need research.

This changes what progress might look like. A less elaborate route to a suitable food ingredient could be commercially more important than a spectacular increase in the size of the vessel. Conversely, impressive production inside the fermenter could coexist with difficult recovery outside it. Looking only at the first stage makes the second kind of limitation disappear.

Consider an illustrative process that makes 100 units of a target substance but recovers 70 usable units. Another makes 90 and recovers 85. The figures are invented, and do not describe any company. They simply show why a larger upstream number is not automatically a larger saleable output. The final comparison also needs time: 85 recovered units every four days and 70 every two days would reverse the ranking of daily output. That added assumption is fictional too. It separates the amount in a batch from the rate at which a factory can keep supplying it.

Recovery can affect the ingredient’s behavior too. A food customer does not purchase an abstract molecular diagram; it purchases material made through a process. If changes intended to improve production alter the material’s useful performance, the supplier and customer need to understand that together. Optimizing one stage while leaving another to absorb the consequence is a poor way to build a repeatable product.

At the recipe: the molecule is not the whole food

A particular milk protein supplies one component of a glass of milk; an egg protein supplies one component of an egg. Fat, water and other constituents still have to be arranged into the intended food. That formulation work is where the supplier’s specification meets the customer’s recipe.

The supplier may aim to deliver a protein with dependable behavior. The food manufacturer may need a particular texture, flavor, composition and shelf life from a mixture of ingredients. Those objectives meet in formulation work. A successful replacement in one use does not establish a direct substitution in every recipe where the original ingredient appears.

This is a better place to evaluate the technology than a contest between labels. “Animal-free” describes a production claim; the intended food still has to work. A customer may value a new ingredient because it provides a useful function, stabilizes supply or fits a product’s positioning. Different customers can assign different importance to those advantages.

The comparison should therefore use the relevant application. If two materials achieve the desired texture at different amounts, a price per kilogram alone is incomplete. The customer needs the cost of providing the function in the finished food, including any other changes required. An inexpensive powder that forces an expensive reformulation may be a poor bargain; a more expensive ingredient could be worthwhile if it solves a difficult production problem.

The eating experience remains part of that account. A promising ingredient does not establish that people will enjoy a finished product or buy it repeatedly. Those are questions for actual foods and customers. The stainless-steel image can introduce the technology, but it cannot do the tasting on anyone’s behalf.

At the label: the absence of an animal does not settle an allergy

The distinction between production method and composition becomes especially consequential when a familiar protein is made in a new way. Consumers need information about what the food contains, not only the route through which it was made.

The FDA’s 2020 response to GRAS Notice 863, concerning fermentation-produced beta-lactoglobulin, records the notifier’s conclusion that the protein can cause reactions in people with milk allergies. The agency’s response is a “no questions” letter about the notified GRAS conclusion, not a blanket approval of precision-fermented foods. The document also addresses the need for relevant allergen labeling.

That example is enough to defeat a careless inference: avoiding a cow in production does not by itself mean avoiding the allergy associated with a milk protein. It also should not be confused with a claim about lactose, a different component. Product-specific information is essential; people should not have to decode a broad marketing term to find it.

Current FDA food-allergy guidance emphasizes checking labels and avoiding foods to which a person is allergic. The principle is straightforward even when production is novel. Clear communication of the relevant composition needs to accompany the new story about where the ingredient comes from.

Regulatory procedures likewise follow products and jurisdictions. EFSA assesses the safety of novel-food applications, while the European Commission and Member State authorities decide on authorization and conditions. A favorable development for one ingredient elsewhere cannot be used as permission for every new protein in every market.

At the factory gate: a larger vessel is not an annual sales figure

Capacity is a possibility expressed through equipment and an operating plan. Sales require output that meets specifications and finds a buyer. Between them sit production scheduling, reliability, quality checks, maintenance, recovery and the customer’s own qualification process.

The distinction matters when a headline announces litres of fermentation capacity. Litres describe space for a process, not directly tonnes of ingredient ready for sale. Different processes can produce different amounts over different times, with different recovery outcomes. Converting volume to commercial output requires the assumptions connecting those quantities.

A food customer also needs consistency across deliveries. An excellent sample helps begin a relationship, but a factory needs to reproduce the required result. If the buyer has to change its recipe frequently to accommodate variable material, the supplier is passing operational work downstream. Reliable specifications are part of the ingredient’s value.

Contracted production creates another set of questions. A company may use someone else’s equipment rather than own a new plant. That can be a sensible way to develop supply, but access, scheduling and responsibilities then become important. Owning the tank and having dependable access to a suitable process are different arrangements, neither automatically superior.

The business model needs to fit the ingredient as well. A specialized ingredient with a valuable function and a bulk protein competing largely on price face different markets. Their revenues cannot be inferred from the same technology label. A useful factory may serve a narrow role very well without replacing an entire food category.

Beyond the fence: the environmental promise needs the production account

The potential environmental benefits should be investigated through a defined process and comparison. Inputs, utilities, recovery, waste handling and the intended replacement all contribute to the result. An efficient imagined future plant and an operating facility today are different subjects for an assessment.

This need for specificity also appears in safety discussions. FAO’s January 2026 account of its stakeholder roundtable emphasizes production steps, inputs and product characteristics. The report concerns discussions held in October 2024; its publication does not establish a new universal authorization or certify an individual facility.

For environmental claims, a transparent account should explain which ingredient is being replaced, at what useful quantity and with which production assumptions. Comparing equal masses may be appropriate in one case; comparing equal functions may be more revealing in another. The question needs to be chosen before the favorable result is selected.

Such an account can identify where improvement would matter most. If recovery is resource-intensive, attention belongs there. If the input supply dominates a particular impact, a bigger tank alone will not resolve it. If the finished product requires several additional ingredients, those should not vanish at the assessment’s edge.

The promising story is therefore less cinematic and more practical than the factory photograph. A producer makes something useful, recovers it efficiently, meets a clear specification and supplies a food people want. It demonstrates the relevant safety and environmental claims with evidence suited to the product. That is what turns microbial capability into a food business.